Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 46 to 60 of 68 results for diabetic foot

  1. Prevention strategies for Charcot arthropathy:- What strategies may be useful in the prevention of Charcot arthropathy?

    sequelae. Source guidance details Comes from guidance Diabetic foot problems: prevention and management Number NG19 Date

    Research recommendation
    Published
    12 October 2015

  2. Type 2 diabetes prevention: population and community-level interventions (PH35)

    This guideline covers preventing type 2 diabetes in adult populations and communities who are at high risk. It aims to promote a healthy diet and physical activity at community and population level, and recommends how to tailor services for people in ethnic communities and other groups who are particularly at risk of type 2 diabetes.

    Public health guideline
    Published
    10 May 2011
    View recommendations

    Sections for PH35

  3. Additional research could help address uncertainties in the evidence, although the case for cost savings remains unlikely. Although the committee acknowledged that the Game et al. (2018) RCT was well conducted, it felt that additional research could help resolve some uncertainties around the cost and clinical case for 3C Patch. Specifically, research identifying the most appropriate stopping rule, and the associated clinical outcomes of implementing the rule, would help address key uncertainties within the cost case. Additional collection of resource use data on unhealed hard-to-heal ulcers could also reduce uncertainty in the cost case. Further to this, evidence could be collected on an UrgoStart-experienced population, as this would be reflective of current NHS care. Clinical experts thought a trial on this population would be feasible. The committee concluded that although further research could be done, on balance it was unlikely to result in a cost-saving case for 3C Patch based on the decision problem evaluated in this guidance

    guidance details Comes from guidance 3C Patch for treating diabetic foot ulcers Number MTG66 Date issued March 2022

    Research recommendation
    Published
    8 April 2022

  4. The VAC Veraflo Therapy system for acute infected or chronic wounds that are failing to heal (HTG566)

    Evidence-based recommendations on the VAC Veraflo Therapy system for acute infected or chronic wounds that are failing to heal.

    HealthTech guidance
    Published
    27 January 2021
    View recommendations

    Sections for HTG566

  5. Diabetes: annual foot examination (children T2DM) (IND309)

    This indicator covers the proportion of children and young people aged 12 to 18 years with type 2 diabetes who have a record of a foot examination in the previous 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes

    Network / system level indicators
    Published
    16 April 2025

  6. Diabetes: annual foot examination (children T1DM) (IND308)

    This indicator covers the proportion of children and young people aged 12 to 18 years with type 1 diabetes who have a record of a foot examination in the previous 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes

    Network / system level indicators
    Published
    16 April 2025

  7. What is the most clinically and cost-effective tool for diagnosing peripheral arterial disease in people with diabetes?

    higher risk of cardiovascular events and foot problems such as diabetic neuropathy (nerve damage or degeneration),...

    Research recommendation
    Published
    22 January 2021

  8. Diabetic foot problems: Inpatient management of diabetic foot problems (CG119)

    This guidance has been updated and replaced by NICE guideline NG19.

    Clinical guideline
    Published
    23 March 2011

  9. Further research is needed on the benefits and consequences of detecting preclinical diabetic peripheral neuropathy.

    research is needed on the benefits and consequences of detecting preclinical diabetic peripheral neuropathy. Any explanatory notes(if...

    Research recommendation
    Published
    3 January 2019

  10. Leg ulcer infection: antimicrobial prescribing (NG152)

    This guideline sets out an antimicrobial prescribing strategy for adults with leg ulcer infection. It aims to optimise antibiotic use and reduce antibiotic resistance.

    Antimicrobial prescribing guideline
    Published
    11 February 2020
    View recommendations

    Sections for NG152

  11. Synthetic cartilage implant insertion for first metatarsophalangeal joint osteoarthritis (hallux rigidus) (IPG727)

    Evidence-based recommendations on synthetic cartilage implant insertion for first metatarsophalangeal joint osteoarthritis (hallux rigidus). This involves replacing damaged cartilage with an artificial (synthetic) implant.

    Interventional procedures guidance
    Published
    1 June 2022
    View recommendations

    Sections for IPG727

  12. 3C Patch for treating diabetic foot ulcers (MTG66)

    We have moved Medical technologies guidance 66 to become HealthTech guidance 615. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Medical technologies guidance
    Published
    7 March 2022

  13. 3C Patch System for treating diabetic foot ulcers (MIB230)

    This advice has been updated and replaced by NICE Healthtech guidance 615.

    Medtech innovation briefing
    Published
    27 October 2020

  14. UrgoStart for treating diabetic foot ulcers and leg ulcers (MTG42)

    We have moved Medical technologies guidance 42 to become HealthTech guidance 502. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Medical technologies guidance
    Last updated
    4 April 2023

  15. Prontosan for treating acute and chronic wounds (HTG616)

    Evidence-based recommendations on Prontosan for treating acute and chronic wounds.

    HealthTech guidance
    Published
    8 March 2022
    View recommendations

    Sections for HTG616